Trial Profile
Clinical Trials Insight: 700049152
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 25 Sep 2009
Price :
$35
*
At a glance
- Drugs Retigabine (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Bausch Health Companies
- 25 Sep 2009 New trial record.